Stay updated on GEMINI 1 Tolebrutinib Clinical Trial
Sign up to get notified when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.

Latest updates to the GEMINI 1 Tolebrutinib Clinical Trial page
- Check3 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home button, replacing the expected study record details. This indicates restricted access to the content rather than an update to the study data.SummaryDifference17%

- Check10 days agoChange DetectedThe page revision tag was updated to v3.7.0, indicating a newer iteration of the site template or rendering. The change does not modify the study details or user-facing content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision changed from v3.6.5 to v3.6.6 on the page. This marks an update to the page's version metadata.SummaryDifference0.0%

- Check45 days agoChange DetectedAdds a new citation for 'Tolebrutinib liver safety: A detailed overview' by Maxwell et al., expanding the page’s bibliography with author names. The page revision is updated to v3.6.5, while the prior plain language results summary, Sanofi branding, 'Helpful Links Provided by', and the v3.6.4 revision tag are removed.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision tag, v3.6.4, has been added to replace the previous v3.6.3. This indicates a minor update to the page’s build or documentation without altering substantive content.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.3, indicating a newer version of the document. This update reflects a version-control change rather than a substantive modification to study details.SummaryDifference0.0%

Stay in the know with updates to GEMINI 1 Tolebrutinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.